Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 4
1966 2
1967 3
1968 1
1969 1
1972 1
1973 1
1974 3
1975 3
1976 2
1977 5
1978 7
1979 2
1980 5
1982 3
1983 6
1984 9
1985 17
1986 10
1987 8
1988 14
1989 19
1990 18
1991 27
1992 27
1993 34
1994 29
1995 38
1996 32
1997 32
1998 29
1999 34
2000 40
2001 43
2002 48
2003 37
2004 31
2005 40
2006 42
2007 39
2008 52
2009 44
2010 44
2011 51
2012 48
2013 41
2014 54
2015 48
2016 49
2017 42
2018 39
2019 42
2020 39
2021 41
2022 53
2023 35
2024 63
2025 51

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,449 results

Results by year

Filters applied: . Clear all
Page 1
[Medulloblastoma].
Yamaguchi S, Fujimura M. Yamaguchi S, et al. Among authors: fujimura m. No Shinkei Geka. 2023 Sep;51(5):858-866. doi: 10.11477/mf.1436204827. No Shinkei Geka. 2023. PMID: 37743337 Japanese.
Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial.
Houkin K, Osanai T, Uchiyama S, Minematsu K, Taguchi A, Maruichi K, Niiya Y, Asaoka K, Kuga Y, Takizawa K, Haraguchi K, Yoshimura S, Kimura K, Tokunaga K, Aoyama A, Ikawa F, Inenaga C, Abe T, Tominaga A, Takahashi S, Kudo K, Fujimura M, Sugiyama T, Ito M, Kawabori M, Hess DC, Savitz SI, Hirano T; TREASURE Study Investigators. Houkin K, et al. Among authors: fujimura m. JAMA Neurol. 2024 Feb 1;81(2):154-162. doi: 10.1001/jamaneurol.2023.5200. JAMA Neurol. 2024. PMID: 38227308 Free PMC article. Clinical Trial.
Diagnostic Criteria for Moyamoya Disease - 2021 Revised Version.
Kuroda S, Fujimura M, Takahashi J, Kataoka H, Ogasawara K, Iwama T, Tominaga T, Miyamoto S; Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health, Labor, and Welfare, Japan. Kuroda S, et al. Among authors: fujimura m. Neurol Med Chir (Tokyo). 2022 Jul 15;62(7):307-312. doi: 10.2176/jns-nmc.2022-0072. Epub 2022 May 25. Neurol Med Chir (Tokyo). 2022. PMID: 35613882 Free PMC article.
Adult Moyamoya Disease and Moyamoya Syndrome: What Is New?
Uchiyama S, Fujimura M. Uchiyama S, et al. Among authors: fujimura m. Cerebrovasc Dis Extra. 2024;14(1):86-94. doi: 10.1159/000540254. Epub 2024 Jul 23. Cerebrovasc Dis Extra. 2024. PMID: 39043157 Free PMC article. Review.
[Subarachnoid Hemorrhage].
Endo H, Fujimura M, Tominaga T. Endo H, et al. Among authors: fujimura m. No Shinkei Geka. 2021 Mar;49(2):220-228. doi: 10.11477/mf.1436204382. No Shinkei Geka. 2021. PMID: 33762441 Japanese.
Moyamoya Disease.
Fujimura M, Bang OY, Kim JS. Fujimura M, et al. Front Neurol Neurosci. 2016;40:204-220. doi: 10.1159/000448314. Epub 2016 Dec 2. Front Neurol Neurosci. 2016. PMID: 27960175 Review.
2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society.
Fujimura M, Tominaga T, Kuroda S, Takahashi JC, Endo H, Ogasawara K, Miyamoto S; Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health, Labor Welfare, Japan; Guideline Committee 2021 of the Japan Stroke Society. Fujimura M, et al. Neurol Med Chir (Tokyo). 2022 Apr 15;62(4):165-170. doi: 10.2176/jns-nmc.2021-0382. Epub 2022 Feb 22. Neurol Med Chir (Tokyo). 2022. PMID: 35197402 Free PMC article. No abstract available.
Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC.
Yu HA, Baik C, Kim DW, Johnson ML, Hayashi H, Nishio M, Yang JC, Su WC, Gold KA, Koczywas M, Smit EF, Steuer CE, Felip E, Murakami H, Kim SW, Su X, Sato S, Fan PD, Fujimura M, Tanaka Y, Patel P, Sternberg DW, Sellami D, Jänne PA. Yu HA, et al. Among authors: fujimura m. Ann Oncol. 2024 May;35(5):437-447. doi: 10.1016/j.annonc.2024.02.003. Epub 2024 Feb 17. Ann Oncol. 2024. PMID: 38369013 Free article. Clinical Trial.
1,449 results